Pilot study of repetitive transcranial magnetic stimulation in patients with chemotherapy-induced peripheral neuropathy

被引:11
|
作者
Goto, Yuko [1 ,2 ,3 ]
Hosomi, Koichi [1 ,2 ]
Shimokawa, Toshio [4 ]
Shimizu, Takeshi [5 ]
Yoshino, Kiyoshi [6 ]
Kim, Seung Jin [7 ]
Mano, Tomoo [1 ]
Kishima, Haruhiko [2 ]
Saitoh, Youichi [1 ,2 ]
机构
[1] Osaka Univ, Dept Neuromodulat, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Neurosurg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[3] Yu Neurosurg Clin, Toyonaka, Osaka 5600083, Japan
[4] Wakayama Med Univ, Clin Study Support Ctr, Wakayama, Wakayama 6418509, Japan
[5] Kansai Rosai Hosp, Dept Neurosurg, Amagasaki, Hyogo 6608511, Japan
[6] Univ Occupat & Environm Hlth, Grad Sch Med, Dept Obstet & Gynecol, Kitakyushu, Fukuoka, Japan
[7] Osaka Univ, Dept Breast & Endocrine Surg, Grad Sch Med, Suita, Osaka 5650871, Japan
关键词
Repetitive transcranial magnetic stimulation; Chemotherapy-induced peripheral neuropathy; Primary motor cortex; PRIMARY MOTOR CORTEX; QUALITY-OF-LIFE; DOUBLE-BLIND; PAIN RELIEF; RTMS; CROSSOVER; SURVIVORS;
D O I
10.1016/j.jocn.2020.01.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the intractable long-term side effects of anticancer medications and results in pain and dysesthesia. Repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex has been demonstrated to provide effective relief for intractable neuropathic pain. The objective of this study was to investigate the effects of rTMS treatment on CIPN in cancer patients. Materials and methods: Eleven female patients with breast cancer or gynecologic cancer (mean age 64.8 [standard deviation 7.8]) who had neuropathic pain and/or peripheral sensory neuropathy, with a minimum two grade severity based on the scale of the National Cancer Institutes' Common Terminology Criteria for Adverse Events (version 4.0) were enrolled. Patients received rTMS (5-Hz; 500 pulses/session; figure-8 coil) on their primary motor cortex corresponding to the target extremity. The intensity of pain and dysesthesia for all extremities was evaluated using a visual analog scale for pain, dysesthesia, and the Japanese version of the short-form McGill Pain Questionnaire 2 (SFMPQ2). Results: rTMS for target extremity significantly decreased the visual analog scale of pain and dysesthesia. The intensity of pain measured by the SFMPQ2 was also decreased in the target extremity. Regarding non-target extremities, only dysesthesia significantly decreased as a result of rTMS. No adverse events were observed. Conclusion: This is an initial report demonstrating the potential of rTMS for the treatment of CIPN. We suggest rTMS could be potentially beneficial and effective as a treatment for pain and dysesthesia in patients with CIPN. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 50 条
  • [1] Repetitive transcranial magnetic stimulation for chemotherapy-induced peripheral neuropathy in multiple myeloma: A pilot study
    Yan, Zhenzhuang
    Cao, Weiwei
    Miao, Lei
    Li, Juan
    Wang, Hui
    Xu, Dandan
    Yu, Hainan
    Zhu, Yuanxin
    SAGE OPEN MEDICINE, 2023, 11
  • [2] Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy
    Pachman, Deirdre R.
    Weisbrod, Breanna L.
    Seisler, Drew K.
    Barton, Debra L.
    Fee-Schroeder, Kelliann C.
    Smith, Thomas J.
    Lachance, Daniel H.
    Liu, Heshan
    Shelerud, Randy A.
    Cheville, Andrea L.
    Loprinzi, Charles L.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 943 - 951
  • [3] Chemotherapy-induced Peripheral Neuropathy
    Bobylev, I.
    Elter, T.
    Schneider, C.
    Wunderlich, G.
    Zimmer, P.
    Streckmann, F.
    Fink, G. R.
    Lehmann, H. C.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (08) : 427 - 436
  • [4] Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study
    D'Alessandro, Eduardo Guilherme
    Nebuloni Nagy, Daniela Ribeiro
    Moran de Brito, Christina May
    Marinho Almeida, Elisangela Pinto
    Battistella, Linamara Rizzo
    Cecatto, Rebeca Boltes
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (01) : 64 - 72
  • [5] Chemotherapy-induced peripheral neuropathy in the adult
    Saad, Mehdi
    Tafani, Camille
    Psimaras, Dimitri
    Ricard, Damien
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 634 - 641
  • [6] Repetitive transcranial magnetic stimulation for tinnitus: A pilot study
    Smith, Jason A.
    Mennemeier, Mark
    Bartel, Twyla
    Chelette, Kenneth C.
    Kimbrell, Timothy
    Triggs, William
    Dornhoffer, John L.
    LARYNGOSCOPE, 2007, 117 (03) : 529 - 534
  • [7] Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update
    Desforges, Allison D.
    Hebert, Chance M.
    Spence, Allyson L.
    Reid, Bailey
    Dhaibar, Hemangini A.
    Cruz-Topete, Diana
    Cornett, Elyse M.
    Kaye, Alan David
    Urits, Ivan
    Viswanath, Omar
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [8] Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues
    Bae, Esther H.
    Greenwald, Mark K.
    Schwartz, Ann G.
    NEUROTHERAPEUTICS, 2021, 18 (04) : 2384 - 2396
  • [9] Chemotherapy-Induced Peripheral Neuropathy
    Knoerl, Robert
    AMERICAN JOURNAL OF NURSING, 2021, 121 (04) : 26 - 30
  • [10] Chemotherapy-Induced Peripheral Neuropathy
    Jain, Ashish
    Hariprasad, M. G.
    Sharique, Mohammad
    Redhwan, Moqbel Ali Moqbel
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2023, 57 (02) : 342 - 353